Definition
Definite diagnosis of malignant gastrointestinal stromal tumours, classified less than AJCC Stage 2.
The diagnosis of malignant gastrointestinal stromal tumours must be supported by a histolopathological biopsy report and made by a specialist.
For the purposes of this definition, the terms "classified less than AJCC Stage 2" are to be applied as defined in the American Joint Committee on Cancer (AJCC) cancer staging manual, 7th Edition, 2010.
Exclusions
- No benefit will be payable under the definition of "malignant gastrointestinal stromal tumours" if:
Within the first
90 days following the later of, the effective date of this coverage, or the date of last reinstatement of this coverage, the insured person has any of the following:
- signs, symptoms or investigations, that lead to a diagnosis of cancer (covered or excluded under this coverage), regardless of when the diagnosis is made; or
- a diagnosis of cancer (covered or excluded under this coverage).
Obligation to inform the Company
Medical information about the diagnosis and any signs, symptoms or investigations leading to the diagnosis must be reported to the Company within 6 months of the date of the diagnosis.
If this information is not provided within this period, the Company has the right to deny any claim for cancer or any covered condition caused by any cancer or its treatment.
